10112E (2020-06)
Page 1 of 3




 


GROUP INSURANCE – HEALTH CLAIMS

PRIOR AUTHORIZATION REQUEST
EYLEA (AFLIBERCEPT)
LUCENTIS (RANIBIZUMAB)



PLEASE READ THE INSTRUCTIONS ON THE LAST PAGE OF THIS FORM.
    
  
   
 
Signature of physician: Date:
               





Signature of member:
Date:
Last name and rst name of parent/legal guardian (if applicable):
Signature of paent or parent/legal guardian (if applicable): Date:
  
  
  
   
   
 
YYYY MM DD
Yes
No
If so
  
PATIENT SUPPORT
PROGRAM


A
PATIENT IDENTIFICATION


g
PRIVATE PLAN
Yes  Copy aached to this form.

 
No

PROVINCIAL PLAN
g
Yes Copy aached to this form.
No

B
DECLARATION AND AUTHORIZATION FOR THE COLLECTION AND COMMUNICATION OF PERSONAL INFORMATION
Coordinaon of benets: If the paent has coverage under a private insurance plan or is enrolled in a provincial drug insurance plan, please submit the request to this
plan rst. Then send us a copy of the decision noce and this form lled out by the physician, so we can analyze the request.
C
ATTENDING PHYSICIAN SECTION









CONTINUED ON THE BACK
PRINT
NEW REQUEST
C
ATTENDING PHYSICIAN SECTION
Connued
PRIOR MEDICATION OR TREATMENT
Has the paent ever used medicaon or received treatment for this medical condion? Yes No
If not, please explain:
If so, please list any medicaon already used or any treatment already received for this medical condion:
Make sure to ll out all secons so we can process the request faster. If any informaon is missing, we will send the form back to the member.
In order to consider any diagnosis not menoned on this form, we need supporng documents (clinical pracce guidelines, clinical studies, etc.) that jusfy the drug’s
use in the given context.
Page 2 of 3
Diagnosis
Neovascular (wet) age-related macular degeneraon
Visual impairment due to macular edema secondary to central renal vein occlusion (CRVO)
Visual impairment due to macular edema secondary to branch renal vein occlusion (BRVO)
Visual impairment due to diabec macular edema (DME)
Choroidal neovascularizaon secondary to pathological myopia
Other therapeuc indicaon(s) - Please specify:
Informaon relang to neovascular (wet) age-related macular degeneraon
Opmal visual acuity, aer correcon, between 6/12 and 6/96: Yes No
Linear dimension of the lesion less than or equal to 12 disc areas: Yes No
Presence of signicant permanent structural damage to the centre of the macula: Yes No
Has the disease progressed in the last three months? Yes No
If so, please specify: Conrmed by renal angiography Conrmed by opcal coherence tomography Conrmed by recent changes in visual acuity
Treatment administered in conjucon with Verteporn (Visudyne
®
): Yes No Which eye was treated? Right eye Le eye Both eyes
Informaon relang to diabec macular edema
Hemoglobin A1c: % Opmal visual acuity, aer correcon, between 6/9 and 6/96: Yes No
What is the thickness of the central rena? Is photocoagulaon also indicated? Yes No
Informaon relang to choroidal neovascularizaon secondary to pathological myopia
Axial length of the eyeball: mm
Myopia is greater than -6 diopters: Yes No
Opmal visual acuity aer correcon is between 6/9 and 6/96: Yes No
There is intrarenal or subrenal uid or an acve leak due to a choroidal neovascularizaon lesion: Yes No
If so, please specify: Observed by renal angiography Observed by opcal coherence tomography
Informaon relang to visual impairment due to macular edema secondary to renal vein occlusion (RVO) or to branch renal vein occlusion (BRVO)
Opmal visual acuity, aer correcon: Between 6/9 and 6/96 Between 6/12 and 6/120
What is the thickness of the central rena? Is there absence of aerent pupillary defect: Yes No
Prescripon renewal
Necessary informaon to assess response to treatment aer three months or more. Please include the results of the following 2 exams:
Le eye
Assessement of visual acuity measured with Snellen chart
Date : Stabilizaon Improvement Degradaon
Assessment of macular edema with an opcal coherence tomography
Date : Stabilizaon Improvement Degradaon
YYYY MM DD
YYYY MM DD
Right eye
Assessement of visual acuity measured with Snellen chart
Date : Stabilizaon Improvement Degradaon
Assessment of macular edema with an opcal coherence tomography
Date : Stabilizaon Improvement Degradaon
YYYY MM DD
YYYY MM DD
YYYY MM DD
MEDICATION OR TREATMENT NAME
OUTCOME
Name:
Dose:
Name:
Dose:
Name:
Dose:
Name:
Dose:
Ineciency Intolerance Contraindicaon
Specify:
Ineciency Intolerance Contraindicaon
Specify:
Specify:
Specify:
Ineciency Intolerance Contraindicaon
Ineciency Intolerance Contraindicaon
TREATMENT PERIOD
From:
To:
From:
To:
From:
To:
From:
To:
YYYY MM DD
YYYY MM DD
YYYY MM DD
YYYY MM DD
YYYY MM DD
YYYY MM DD
YYYY MM DD
Page 3 of 3















 







D
INSTRUCTIONS – HOW TO COMPLETE AND RETURN THIS FORM
 

